Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Research & Development (2020 - 2022)

Historic Research & Development for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $10.7 million.

  • Terns Pharmaceuticals' Research & Development rose 1264.0% to $10.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $39.6 million, marking a year-over-year increase of 2652.74%. This contributed to the annual value of $70.1 million for FY2024, which is 1041.78% up from last year.
  • Terns Pharmaceuticals' Research & Development amounted to $10.7 million in Q4 2022, which was up 1264.0% from $12.2 million recorded in Q3 2022.
  • Terns Pharmaceuticals' Research & Development's 5-year high stood at $12.2 million during Q3 2022, with a 5-year trough of $5.4 million in Q3 2020.
  • Moreover, its 3-year median value for Research & Development was $8.0 million (2020), whereas its average is $8.2 million.
  • In the last 5 years, Terns Pharmaceuticals' Research & Development plummeted by 2167.91% in 2021 and then surged by 7001.26% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Research & Development (Quarter) stood at $7.8 million in 2020, then grew by 21.78% to $9.5 million in 2021, then grew by 12.64% to $10.7 million in 2022.
  • Its Research & Development was $10.7 million in Q4 2022, compared to $12.2 million in Q3 2022 and $8.7 million in Q2 2022.